News for McKesson Corporation (M1CK34.SA)

McKesson Corporation (NYSE: MCK) will release its first quarter fiscal 2026 financial results after market close on Wednesday, August 6, 2025. The company will

/PRNewswire-PRWeb/ -- TAXIS Pharmaceuticals, a clinical stage company at the forefront of developing therapies to treat multidrug-resistant bacterial...

McKesson (MCK) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

The preventive healthcare technologies and services market size was valued at USD 284.42 billion in 2024 and is projected to reach USD 668.15 billion by 2032, expanding at a robust CAGR of 11.28%…

Alluvium Asset Management, an asset management company, released its “Conventum – Alluvium Global Fund” first-quarter 2025 investor letter. A copy of the letter can be downloaded here.

McKesson Corporation (NYSE:MCK) is one of the 12 best healthcare stocks to buy now. On June 11, Morgan Stanley reiterated the stock’s ‘Overweight’ rating and increased the price target to $770 from $745. The adjustment follows a discussion with the executive team that left the research firm optimistic about the company’s growth prospects. According to […]

McKesson Corporation (NYSE:MCK) is one of the best 52-week high stocks to buy, according to analysts. On June 10, Wells Fargo reiterated an Equal Weight on the stock and a $766 price target. The bullish stance is in response to the company increasing its full-year earnings per share guidance by 0.5%. The company has raised […]

ANGEL INVESTORS. Discover how Columbus, Ohio's angel investors can fuel your startup's growth. Unlock funding and mentorship—read now!

Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

On June 9, 2025, McKesson Corporation (MCK) announced updates to its Fiscal Year 2026 financial outlook during meetings with investors and analysts. The compa

McKesson Corporation (NYSE:MCK) announced that it has finalized the purchase of a majority stake in Community Oncology Revitalization Enterprise Ventures, LLC (Core Ventures), a business and administrative...

McKesson Corporation acquires 70% of Core Ventures for $2.49 billion, enhancing oncology care. Partnership with Florida Cancer Specialists & Research In

McKesson (MCK) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

We recently published a list of 8 Stocks on Jim Cramer’s Radar Recently. In this article, we are going to take a look at where McKesson Corporation (NYSE:MCK) stands against other stocks that Jim Cramer discussed recently. On Wednesday’s episode of Mad Money, Jim Cramer reviewed the recent developments affecting drug distribution companies and laid […]

On May 8, 2025, McKesson Corporation announced its intention to separate its Medical-Surgical Solutions segment into an independent company.

Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

McKesson Corporation (NYSE:MCK) BofA Securities 2025 Healthcare Conference May 13, 2025 11:00 AM ETCompany ParticipantsBritt Vitalone - Chief Financial...

Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here.

Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund returned 2.54% (Institutional Shares) in the quarter compared to a 3.87% gain for the Russell 3000 Health Care Index (benchmark) and a 4.72% decline for the Russell […]